| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,295 |
6,629 |
$739K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,737 |
9,434 |
$715K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
10,259 |
9,683 |
$392K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,676 |
3,530 |
$376K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,995 |
2,879 |
$304K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,854 |
2,633 |
$279K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,058 |
1,918 |
$218K |
| 99215 |
Prolong outpt/office vis |
1,573 |
1,465 |
$217K |
| 99174 |
|
2,531 |
2,423 |
$46K |
| 99173 |
|
5,288 |
4,960 |
$36K |
| 92551 |
|
5,604 |
5,262 |
$33K |
| 36416 |
|
8,974 |
8,465 |
$28K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,666 |
2,461 |
$27K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,490 |
1,617 |
$25K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
704 |
658 |
$25K |
| 96127 |
|
1,118 |
1,049 |
$12K |
| 83655 |
|
958 |
938 |
$10K |
| 99442 |
|
219 |
206 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
200 |
186 |
$8K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
645 |
583 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
28 |
27 |
$5K |
| 99381 |
|
41 |
41 |
$5K |
| 96161 |
|
244 |
222 |
$4K |
| 80061 |
Lipid panel |
363 |
307 |
$3K |
| 99070 |
|
1,215 |
1,140 |
$2K |
| 94760 |
|
1,443 |
1,315 |
$2K |
| 99443 |
|
12 |
12 |
$714.89 |
| 95012 |
|
61 |
57 |
$647.40 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
118 |
115 |
$614.72 |
| 99188 |
|
12 |
12 |
$240.00 |
| 81002 |
|
182 |
168 |
$2.44 |
| 90677 |
|
153 |
152 |
$0.58 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
230 |
208 |
$0.08 |
| 90686 |
|
4,618 |
4,422 |
$0.01 |
| 90685 |
|
30 |
29 |
$0.01 |
| 90723 |
|
759 |
737 |
$0.00 |
| 85018 |
|
14 |
12 |
$0.00 |
| 90696 |
|
158 |
152 |
$0.00 |
| 90698 |
|
642 |
604 |
$0.00 |
| 90651 |
|
594 |
543 |
$0.00 |
| 99000 |
|
57 |
40 |
$0.00 |
| 90697 |
|
69 |
67 |
$0.00 |
| 90716 |
|
128 |
127 |
$0.00 |
| 90656 |
|
240 |
240 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
14 |
12 |
$0.00 |
| 90707 |
|
109 |
108 |
$0.00 |
| 90734 |
|
780 |
734 |
$0.00 |
| 90670 |
|
2,017 |
1,938 |
$0.00 |
| 90681 |
|
645 |
633 |
$0.00 |
| 90648 |
|
728 |
707 |
$0.00 |
| 90633 |
|
1,059 |
1,024 |
$0.00 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
642 |
583 |
$0.00 |
| 90715 |
|
152 |
143 |
$0.00 |
| 90710 |
|
181 |
170 |
$0.00 |
| J7614 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
65 |
63 |
$0.00 |